Immunocore Holdings (IMCR) Change in Working Capital (2021 - 2022)

Immunocore Holdings (IMCR) posted quarterly Change in Working Capital of $79759.1 for Q4 2022, up 154.79% year-on-year from $31304.5 in Q4 2021, and down 47.94% on a QoQ basis from $153211.3 in Q3 2022.

Immunocore Holdings (IMCR) Change in Working Capital (2021 - 2022) Analysis & Trends

Immunocore Holdings (IMCR) has reported Change in Working Capital for 2 consecutive years, with $79759.1 the latest figure, recorded in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immunocore Holdings 1.80 Bn 957.43 Mn 106.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 79,759.13
Dec 31, 2022 79,759.13
Sep 30, 2022 153,211.28
Sep 30, 2022 153,211.28
Dec 31, 2021 -145,585.15
Dec 31, 2021 -145,585.15